IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,000 | -13.4% | 10,000 | 0.0% | 0.40% | -20.9% |
| Q2 2023 | $599,600 | +21.3% | 10,000 | 0.0% | 0.51% | +17.1% |
| Q1 2023 | $494,400 | -13.4% | 10,000 | 0.0% | 0.43% | -12.1% |
| Q4 2022 | $570,700 | +21.7% | 10,000 | 0.0% | 0.49% | +28.3% |
| Q3 2022 | $469,000 | +25.7% | 10,000 | 0.0% | 0.38% | +13.6% |
| Q2 2022 | $373,000 | – | 10,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
| Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
| Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
| TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
| Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
| Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
| RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
| Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
| Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
| Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |